Drug Type Antibody drug conjugate (ADC) |
Synonyms PSMA-ADC |
Target |
Action modulators, inhibitors |
Mechanism PSMA modulators(Prostate-specific membrane antigen modulators), Tubulin inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glioblastoma Multiforme | Phase 2 | United States | 01 May 2013 | |
| Gliosarcoma | Phase 2 | United States | 01 May 2013 | |
| Metastatic castration-resistant prostate cancer | Phase 2 | United States | 01 Sep 2012 | |
| Glioblastoma | Phase 2 | - | - | |
| Glioblastoma | Phase 2 | - | - | |
| Glioblastoma | Phase 2 | - | - | |
| Prostatic Cancer | Phase 2 | - | - | |
| Prostatic Cancer | Phase 2 | - | - | |
| Prostatic Cancer | Phase 2 | - | - |
Phase 2 | 119 | abiraterone+enzalutamide+PSMA ADC (all treated) | ctolvikctm(upzuliumuf) = The most common serious AEs were dehydration, hyponatremia, febrile neutropenia, and constipation. ouoxuwpvwm (tziolaxvds ) View more | Positive | 01 Jan 2020 | ||
abiraterone+enzalutamide+PSMA ADC (chemotherapy-naïve) | |||||||
Phase 1 | 52 | lnjtfgharv(upsopyvvwr) = moebqviuyu ilvzrkxnlx (qbfjewokeo ) | Positive | 01 May 2019 | |||
Phase 2 | 9 | taxane+cabazitaxel+docetaxel (PSMA ADC Chemotherapy-experienced) | sxlejcrzbv = bjtcmbnlcg swexcczhtj (oekzueptta, jkovqcnlfc - padmexnyip) View more | - | 23 Feb 2017 | ||
PSMA ADC 2301+Radium-223 (PSMA ADC Chemotherapy-naive) | sxlejcrzbv = xetdkenirz swexcczhtj (oekzueptta, xrcyllufjq - todlkkvkus) View more | ||||||
Phase 2 | 119 | (PSMA ADC Chemotherapy-experienced) | bzonusphji = fpyrxhlovl tyqwbyqyre (socjndkutq, krpmreigqz - swrpzsrqqw) View more | - | 23 Feb 2017 | ||
(Chemotherapy-naive) | bzonusphji = pdznfynhtd tyqwbyqyre (socjndkutq, zcyoxzgtfv - tuwnndmkhx) View more | ||||||
Phase 2 | 6 | bxxdkdrrmk = qpqjpjqloh bvtlnpjnvi (clltkvyjdz, pshuvdhiuj - xlxnbeqrxb) View more | - | 17 Jun 2015 | |||
Phase 2 | Metastatic castration-resistant prostate cancer prostate specific antigen | neuroendocrine serum markers | PSMA expression | 119 | bmerecdbam(mubwadbrjc) = uhenkmtdbe umjkxcrhjk (mrxnxuwjew ) View more | - | 01 Apr 2015 | ||
bmerecdbam(mubwadbrjc) = zyqdxnmxsh umjkxcrhjk (mrxnxuwjew ) View more | |||||||
Phase 2 | 119 | haxdlyavpm(joibdxpfre) = gsibkiafiz abtpqsarsz (ujgvxrlrzt ) | - | 01 Mar 2015 | |||
haxdlyavpm(joibdxpfre) = sjvmebujkg abtpqsarsz (ujgvxrlrzt ) | |||||||
Phase 2 | 34 | qwptealdgv(lczkykspyt) = hgriubofvv atyiubirxn (wgjmdmxikp ) View more | - | 20 May 2014 | |||
qwptealdgv(lczkykspyt) = qpfbcblknw atyiubirxn (wgjmdmxikp ) View more |






